Wednesday, June 11, 2008

Itero Biopharmaceuticals Raises $21M

San Mateo-based Itero Biopharmaceuticals, a developer of novel therapeutic proteins and antibodies, said Wednesday that it has raised $21M in a Series A venture funding. The funding came in conjunction with a partnership with Indian firm Biological E. Limited. According to Itero, the firm and Biological E. will collaborate on obtaining worldwide approvals and commercialize jointly developed biopharmaceuticals. More information »